A journey through anticoagulant therapies in the treatment of left ventricular thrombus in post-COVID-19 heparin-induced thrombocytopenia: a case report.
Alberto Lázaro-GarcíaInés Martínez-AlfonzoRosa Vidal-LasoDiego Velasco-RodríguezMarta Tomás-MallebreraMarta González-RodríguezPilar Llamas-SilleroPublished in: Hematology (Amsterdam, Netherlands) (2022)
The clinical presentation of intraventricular and multiple arterial thrombi is remarkable. SARS-CoV-2 infection likely contributed to a hypercoagulable state. The management of patients with HIT undergoing cardiac surgery is challenging. If surgery cannot be delayed, then treatment with bivalirudin is recommended. Additionally, this drug is recommended for PCI. Bivalirudin is safe and well-tolerated in both procedures.
Keyphrases
- percutaneous coronary intervention
- cardiac surgery
- left ventricular
- venous thromboembolism
- minimally invasive
- heart failure
- acute myocardial infarction
- coronary artery disease
- atrial fibrillation
- emergency department
- combination therapy
- coronary artery bypass
- drug induced
- mitral valve
- st elevation myocardial infarction
- coronary artery bypass grafting
- cardiac resynchronization therapy